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Dravet syndrome is a severe epileptic encephalopathy mainly caused by heterozygous mutations in the SCN1A
geneencodingavoltage-gatedsodiumchannelNav1.1.WepreviouslyreporteddenselocalizationofNav1.1inpar-
valbumin (PV)-positive inhibitory interneurons in mice and abnormal ﬁring of those neurons in Nav1.1-deﬁcient
mice. In the present study, we investigated the physiologic consequence of selective Nav1.1 deletion in mouse
global inhibitory neurons, forebrain excitatory neurons or PV cells, using vesicular GABA transporter (VGAT)-
Cre,emptyspiracleshomolog1(Emx1)-CreorPV-Crerecombinasedrivers.WeshowthatselectiveNav1.1deletion
using VGAT-Cre causes epileptic seizures and premature death that are unexpectedly more severe than those
observed in constitutive Nav1.1-deﬁcient mice. Nav1.1 deletion using Emx1-Cre does not cause any noticeable
abnormalities in mice; however, the severe lethality observed with VGAT-Cre-driven Nav1.1 deletion is rescued
by additional Nav1.1 deletion using Emx1-Cre. In addition to predominant expression in PV interneurons, we
detected Nav1.1 in subpopulations of excitatory neurons, including entorhino-hippocampal projection neurons,
a subpopulation of neocortical layer V excitatory neurons, and thalamo-cortical projection neurons. We further
show that even minimal selective Nav1.1 deletion, using PV-Cre, is sufﬁcient to cause spontaneous epileptic
seizures and ataxia in mice. Overall, our results indicate that functional impairment of PV inhibitory neurons
with Nav1.1 haploinsufﬁciency contributes to the epileptic pathology of Dravet syndrome, and show for the ﬁrst
time that Nav1.1 haploinsufﬁciency in excitatory neurons has an ameliorating effect on the pathology.
INTRODUCTION
Heterozygous mutations in the SCN1A gene, which encodes a
voltage-gatedsodiumchannelaIsubunit(Nav1.1),areassociated
with a wide spectrum of childhood epilepsies, including general-
ized epilepsy with febrile seizures [Mendelian Inheritance in
Man (MIM) #604233], and Dravet syndrome (MIM #607208)
(1–8).Dravetsyndromeisanintractableepilepticencephalopathy
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autisticbehaviors,ataxiaandincreasedriskofsuddenunexpected
deathinepilepsy(SUDEP)(9,10).Nav1.1haploinsufﬁciencyhas
been implicated in Dravet syndrome pathology (11–13)a n di n
mice, causes epileptic seizures, ataxia (14,15), learning/memory
impairments and abnormal social behaviors (16,17). Previously,
weshoweddenseNav1.1expressionattheaxonsandsomaofpar-
valbumin (PV)-positive interneurons, a subclass of GABAergic
inhibitory neurons, in the hippocampus and neocortex. In Scn1a
heterozygous knock-out mice, these cells exhibit pronounced
spike amplitude decrements in trains of evoked action potentials.
Therefore,basedontheseobservations,weproposedthatimpaired
functions of PV interneurons arising from Nav1.1 haploinsufﬁ-
ciency contribute to the generation of seizures in patients with
Dravet syndrome (15). A recent study conﬁrmed predominant
Nav1.1 expression in PV interneurons (18).
Cheah et al.( 19) recently reported spontaneous epileptic sei-
zuresinmicewithaconditionalNav1.1deletionmediatedbythe
distal-less homeobox (Dlx)1/2-l12b enhancer + b-globin pro-
moter Cre driver (Dlx1/2-Cre) (19), which express Cre recombin-
ase selectively in nearly all forebrain GABAergic inhibitory
neurons (20). Subsequently, Dutton et al.( 18) reported increased
ﬂurothyl- and hyperthermia-induced seizure susceptibilities in
mice with conditional Nav1.1 inactivation, mediated by the
protein phosphatase 1 regulatory subunit 2 (Ppp1r2)p r o m o t e r -
drivenCredriver(Ppp1r2-Cre)(18),whichexpressCrerecombin-
aseinasubsetofforebrainGABAergicneuronsmainlyconsisting
of PV interneurons, but also including reelin- and neuropeptide
Y-positive inhibitory neurons (21). Dutton et al.( 18)a l s o
showed that Emx1-Cre-dependent Nav1.1 inactivation did not
alter ﬂurothyl- and hyperthermia-induced seizure susceptibilities
inmice.Thesestudiesprovideimportantinsightsintothefunction-
al roles of neuronal subtypes in the epileptic pathology of Dravet
syndrome. However, much remains to be investigated, including
theeffectontheepilepticpathology,ofNav1.1deletioninPVcells.
Here, we report that selective Nav1.1 deletion in global inhibi-
toryneurons,viaVGAT-Crerecombination,causessevereepileptic
seizuresandsuddendeathinmice.Althoughpreviousstudiesshow
thatPpp1r2-CreorDlx1/2-Cre-driven elimination ofNav1.1leads
tocomparableorevenmilderphenotypes,comparedwithconstitu-
tive Scn1a knock-out mice (18,19), our VGAT-Cre-driven elimin-
ation of Nav1.1 in global inhibitory neurons results in a more
severephenotypethanconstitutiveScn1aknock-outmice.Further-
more,weshowthatadditionalNav1.1deletioninmouseexcitatory
neurons, using Emx1-Cre recombination, does not cause any no-
ticeable abnormalities on its own, but improves the severe pheno-
type observed in mice with VGAT-Cre-dependent Nav1.1
deletion.Inaddition,weshowthataminimalamountofPV-Cre-
drivenNav.1.1deletionissufﬁcienttocausespontaneousepilep-
ticseizuresandataxiainmice.TheseresultsindicatethatNav1.1
haploinsufﬁciency in excitatory neurons has an ameliorating
effect in Dravet syndrome, and support our previous proposal
that functional impairment of PV interneurons is the cellular/
circuit basis of epileptic pathology in Dravet syndrome (15).
RESULTS
Generation of mice with a ﬂoxed Scn1a allele
We generated mice with a ﬂoxed Scn1a allele, containing two
loxP cassettes placed on either side of coding exon 7 (Fig. 1A
and Supplementary Material, Fig. S1). Mice homozygous for
the ﬂoxed allele (Scn1a
ﬂ/ﬂ) were viable with no obvious abnor-
mal phenotypes, and expressed normal Nav1.1 levels in the
brain (Fig. 1B). Next, we generated mice with a constitutively
deleted Scn1a allele by crossing Scn1a
ﬂ/ﬂ mice and EIIa-Cre
mice, in which the Cre-loxP recombination occurs in germline
cells (Fig. 1A and C) (22). Homozygous (Scn1a
d/d) progeny
were viable with no obvious abnormal phenotypes in the ﬁrst
postnatal week. However, the mice developed severe ataxia at
around postnatal day 10 (P10) and generalized convulsive sei-
zuresaroundP12(Fig.1DandE).Scn1a
d/dmicealsodeveloped
malnutrition in the third postnatal week, probably due to ataxia
andrecurrentseizures,anddiedbeforeP20withanaveragelife-
span of 16.2 days (n ¼ 19) (Fig. 1F). Heterozygous (Scn1a
d/+)
progeny were viable with no obvious abnormal phenotypes
until the beginning of the third postnatal week. By the end of
the third postnatal week, the mice developed recurrent seizures.
Some Scn1a
d/+ mice suffered sporadic sudden death after P18,
and 25.0% (9 of 36) died before P90 (Fig. 1F). These clinical
manifestationsofScn1a
d/dandScn1a
d/+micearevirtuallyiden-
tical to those previously reported in Nav1.1-null mice (14,15),
indicating that mice carrying the ﬂoxed Scn1a allele can serve
asusefultoolsforthedissectionofthephysiologicconsequences
of Nav1.1 deletion, in genetically deﬁned neuronal subtypes,
using the Cre-loxP system.
Selective Nav1.1 deletion in global inhibitory neurons
in mice causes epileptic seizures with higher lethality
than constitutive knock-outs
To assess the physiologic consequences of Nav1.1 deletion in
global GABAergic neurons, we generated a BAC transgenic
mouse line with Cre recombinase expression under the control
of the promoter for vesicular GABA transporter (VGAT) that
is expressed in glycinergic and GABAergic inhibitory neurons
(23,24) (Fig. 2A). The Vgat-Cre BAC transgenic (VGAT-Cre)
mice were viable with no obvious abnormal phenotypes. Im-
munohistochemical investigation of VGAT-Cre,Rosa26-LacZ
double-mutantmice(25)revealedthattransgenicVgatpromoter-
drivenCre-loxPrecombinationoccurredwidelyinbraintissue,in-
cluding the olfactory bulb, striatum, neocortex, hippocampus,
cerebellum, medulla and pons (Fig. 2B). Immunoﬂuorescent
examination showed b-galactosidase immunosignals present in
96.5%(1816of1882)and93.8%(422of450)ofGABA-positive
cellsinthehippocampusandneocortex,respectively(Fig.2C–J),
suggesting transgenic Vgat promoter-driven Cre-loxP recombin-
ation occurred globally, in whole populations of GABAergic
neurons. Conversely, 99.0% (1816 of 1835) and 88.5% (422 of
477) of b-galactosidase-positive cells were positive for GABA
in the hippocampus and neocortex, respectively, suggesting
transgenic Vgat promoter-driven Cre-loxP recombination may
be restricted to global inhibitory neurons.
WenextgeneratedmicewithheterozygousNav1.1deletionin
global inhibitory neurons (Scn1a
ﬂ/+,VGAT-Cre) by crossing
Scn1a
ﬂ/ﬂ and VGAT-Cre mice. PCR analysis of DNA from
Scn1a
ﬂ/+,VGAT-CrewholebrainveriﬁedVGAT-Cre-dependent
recombinationoftheﬂoxedScn1aallele(Fig.3A).Westernblot
analysis showed Nav1.1 expression in P21.5 Scn1a
ﬂ/+,
VGAT-Cre whole brain was reduced to 72.3+3.4% level of
thatinScn1a
ﬂ/+mice(Fig.3BandC).Untilthesecondpostnatal
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ﬂ/+,VGAT-Cre mice were viable and physically in-
distinguishable fromScn1a
ﬂ/+mice,butataroundP16themice
developed spontaneous generalized convulsive seizures
(Fig. 3D and E), which occasionally led to immediate death. In
all three recorded lethal seizure cases, postictal electrocortico-
graphy (ECoG) activity progressively decreased, becoming un-
detectable within a minute after the end of the seizure (Fig. 3E).
Maintenance of postictal ECoG activity until recovery from
postictalimmobilityandECoGsuppressionensuredgeneralized
convulsionsdidnotleadtodeath.Remarkably,allbutone(64of
65;98.5%)Scn1a
ﬂ/+,VGAT-CremicediedbeforeP35(Fig.3F),
and their under-P35 mortality rate was signiﬁcantly higher than
constitutive heterozygous Scn1a knock-out mice (Scn1a
d/+
mice, 8 of 36; 22.2%).
WealsogeneratedmicewithhomozygousNav1.1deletionin
global inhibitory neurons (Scn1a
ﬂ/ﬂ,VGAT-Cre) (see Materials
and Methods) (Fig. 3G). Western blot analysis showed that
Nav1.1 expression in P12.5 Scn1a
ﬂ/ﬂ,VGAT-Cre whole brain
was reduced to 57.6+9.9% level of that in Scn1a
ﬂ/ﬂ mice
(Fig. 3H and I). Scn1a
ﬂ/ﬂ,VGAT-Cre mice were viable and
showed no obvious abnormalities until around P10. However,
afterapproximatelyP11,themiceexhibitedbehavioralhypoac-
tivity,exceptforperiodicmyoclonus-likejerkymovements,and
alldiedbeforeP15(Fig.3F).Theaverage lifespan forScn1a
ﬂ/ﬂ,
VGAT-Cre mice (12.8 days; n ¼ 4) was shorter than Scn1a
d/d
mice (16.2 days; n ¼ 19). Scn1a
ﬂ/ﬂ,VGAT-Cre mice did not
develop severe ataxia and walked normally until a day before
their death.
Weusedimmunohistochemistrytoexaminethespatialpattern
ofNav1.1expressioninP12.5Scn1a
ﬂ/ﬂ,VGAT-Crebrain(Fig.4),
usingananti-Nav1.1antibodywhosespeciﬁcityhasbeenveriﬁed
using Nav1.1-null mice as negative controls (15). P12.5 was the
oldest age used because of the high mortality rate beyond P10
and the short life expectancy (within P15). In the hippocampus
of Scn1a
ﬂ/ﬂ controls, Nav1.1-immunoreactive ﬁbers and puncta
were scattered throughout the CA ﬁelds (Fig. 4A). In contrast,
in Scn1a
ﬂ/ﬂ,VGAT-Cre mice, Nav1.1-immunoreactive ﬁbers and
punctaweremostlyundetectable(Fig.4B).Similarly,intheneo-
cortex, Nav1.1-immunoreactive ﬁbers and puncta were scattered
throughout neocortical layers II/III, IV, V and VI in Scn1a
ﬂ/ﬂ
mice, but virtually undetected in Scn1a
ﬂ/ﬂ,VGAT-Cre mice
(Fig. 4C and D).
In the cerebellum at P12.5, differences in Nav1.1 immunos-
taining patterns and intensities between Scn1a
ﬂ/ﬂ and Scn1a
ﬂ/ﬂ,
VGAT-Cre mice were also observed (Fig. 4E and F), even
though Scn1a
ﬂ/ﬂ,VGAT-Cre mice did not develop ataxia.
Nav1.1-immunoreactive ﬁbers in the inner molecular layer of
the cerebellar lobes, presumably axons of cerebellar basket
Figure1.GenerationofaﬂoxedScn1aalleleinmice.(A)Veriﬁcationofﬂoxedanddeletedexon7allelesusingPCRanalysisofgenomicDNA.Primerpositionsand
PCRproductsizesareindicated.(B)Westernblotanalysisofbrainmembraneproteinspreparedfrom5-month-oldwild-typeandhomozygousﬂoxedScn1a(Scn1a
ﬂ/ﬂ)
mice, using anti-Nav1.1 antibody.b-Tubulinwas used as an internalcontrol, and two independentassays were performed. (C) Western blot analysis of brain mem-
brane proteins prepared from P14.5 Scn1a
+/+, Scn1a
d/+ and Scn1a
d/d littermates, using anti-Nav1.1 antibody. b-Tubulin was used as an internal control, and two
independent assays were performed. (D and E) Representative interictal (D) and ictal (E) ECoG recordings from Scn1a
d/d mice. ECoG recordings were performed
withP14–16Scn1a
d/dmiceandScn1a
+/+ controls(n ¼ 3,eachgroup).(F)SurvivalcurvesofP3Scn1a
+/+,Scn1a
d/+andScn1a
d/dlittermates. +,wild-typeallele;
ﬂ, ﬂoxed allele; d, deleted allele.
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ﬂ/ﬂ, but almost absent in
Scn1a
ﬂ/ﬂ,VGAT-Cre mice (Fig. 4Ea–c and Fa–c). However,
stainingintensitiesinNav1.1-immunoreactiveﬁbersatthebound-
arybetweenthePurkinjeandgranulecelllayers,presumablyaxon
initialsegments(AISs)ofcerebellarPurkinjecells(15),appeared
only slightly decreased in Scn1a
ﬂ/ﬂ,VGAT-Cre mice, compared
withScn1a
ﬂ/ﬂmice(Fig.4EcandFc).IntensitiesofNav1.1immu-
noreactivitiesinpunctascatteredwithinthecerebellarnucleiand
white matter were also slightly reduced in Scn1a
ﬂ/ﬂ,VGAT-Cre
mice, compared with Scn1a
ﬂ/ﬂ mice (Fig. 4Ea and d, 4Fa and
d). Nav1.1 expression in AISs of cerebellar Purkinje cells in
Scn1a
ﬂ/ﬂ,VGAT-Cre mice may explain the absence of apparent
ataxia in these mice.
Selective Nav1.1 deletion in forebrain excitatory
neurons does not cause epileptic seizures in mice
TodeterminewhetherexcitatoryneuronsexpressNav1.1,andif
theydo, what is theirrole inepilepticphenotypes, we employed
the empty spiracles homolog 1 (Emx1)-Cre knock-in mouse
expressingCrerecombinaseunderthecontroloftheendogenous
Emx1 promoter (26). Emx1 is a marker for cortical pyramidal
cells and glia, and is not expressed in GABAergic cells
(27,28). In the Emx1-Cre mouse, Cre recombinase is expressed
in pallium-derived excitatory neurons in various brain regions,
includingtheolfactorybulb,neocortex,piriformcortex,entorh-
inal cortex, hippocampus and amygdala (26).
PCR analysis of DNA from Scn1a
ﬂ/ﬂ, Emx1-Cre whole brain
veriﬁed Emx1-Cre-dependent recombination of the ﬂoxed Scn1a
allele(Fig.5A).WesternblotanalysisshowedthatNav1.1expres-
sioninScn1a
ﬂ/ﬂ,Emx1-Crewholebrainwasreducedto72.1+1.7
and 63.4+2.3% levels of those in Scn1a
ﬂ/ﬂ mice at P21.5 and 8
weeks, respectively (Fig. 5B and C). Homozygous (Scn1a
ﬂ/ﬂ,
Emx1-Cre) mice were viable and with no noticeable abnormal
phenotype, including no convulsive seizures (Fig. 5D).
Nav1.1 is expressed in subpopulations of excitatory neurons
The spatial and temporal patterns of Nav1.1 expression in
Scn1a
ﬂ/ﬂ and Scn1a
ﬂ/ﬂ, Emx1-Cre brains were compared by
Figure 2. Generation of VGAT-Cre transgenic mice. (A) Schematic representation of the DNA construct used to generate the VGAT-Cre transgenic mouse line.
(B)Arepresentativeparasagittalsectionfrom8-week-oldRosa26-LacZ,VGAT-Crebrain,stainedwithanti-b-galactosidaseantibody.Scalebar:300 mm.(C–J)Rep-
resentativeimagesofimmunoﬂuorescencehistochemistryinthehippocampus(C–F)andneocorticallayerII/III(G–J)in8-week-oldRosa26-LacZ,VGAT-Cremice,
stainedwithanti-b-galactosidaseantibody(CandG;green),anti-GABAantibody(DandH;red)andDAPI(EandI;blue),withrespectivemergedimages(FandJ).
Arrowheadsindicatecellsdouble-labeledwithb-galactosidaseandGABA.Notethatcellsimmunopositiveforb-galactosidase(indicativeofCre-loxPrecombination
in the Rosa26-LacZ allele) were usually immunopositive for GABA also. o, stratum oriens; p, stratum pyramidale; r, stratum radiatum. Scale bars: 50 mm.
Human Molecular Genetics, 2013, Vol. 22, No. 23 4787immunohistochemistry. In the hippocampus at P21.5, Nav1.1-
immunoreactive ﬁbers and puncta were clearly observed in the
stratum oriens and pyramidal layers of the CA ﬁelds, in both
Scn1a
ﬂ/ﬂ and Scn1a
ﬂ/ﬂ, Emx1-Cre mice (Fig. 6A and B). In
the neocortex at P21.5, Nav1.1-immunoreactive ﬁbers and
puncta appeared to be distributed similarly in Scn1a
ﬂ/ﬂ and
Scn1a
ﬂ/ﬂ, Emx1-Cre mice; however, subtle differences were
detected(Fig.6CandD).InneocorticallayerVofScn1a
ﬂ/ﬂcon-
trols,Nav1.1immunoreactivitywasdetectedintheproximityof
neurites oriented toward the pial surface (upward), presumably
AISsofPVinterneurons,andalsointheproximityofbasalneur-
ites oriented toward the ventricular surface (downward), of a
Figure 3. Selective Nav1.1 deletion in mouse inhibitory neurons, using VGAT-Cre results in severe epileptic seizures and high lethality. (A) Veriﬁcation of
VGAT-Cre-dependent Scn1a gene deletion in the ﬂoxed allele in P21.5 Scn1a
ﬂ/+,VGAT-Cre brain. PCR analysis of brain genomic DNA isolated from P21.5
Scn1a
ﬂ/+,VGAT-CreandScn1a
ﬂ/ﬂmicewasperformed.(BandC)VeriﬁcationofVGAT-Cre-dependentNav1.1deletionbysemi-quantitativewesternblotanalysis
of brain membrane proteins prepared from P21.5 Scn1a
ﬂ/+, VGAT-Cre mice and Scn1a
ﬂ/ﬂ littermates, using anti-Nav1.1 antibody (B). b-Tubulin was used as an
internal control. Mean Nav1.1 expression levels in Scn1a
ﬂ/+, VGAT-Cre mice are represented as percentages, relative to Nav1.1 in Scn1a
ﬂ/+ littermates (100%;
C). (D and E) Representative ECoG of a lethal seizure in a P18–21 Scn1a
ﬂ/+,VGAT-Cre mouse. An arrow indicates onset of the epileptiform discharge. ECoG
recordingswereperformedwithP18–21Scn1a
ﬂ/+,VGAT-CreandScn1a
ﬂ/+controlmice(n ¼ 3,eachgroup).(F)SurvivalcurvesofP3Scn1a
ﬂ/+,Scn1a
d/+(reprinted
from Fig. 1F for comparison), Scn1a
ﬂ/+,VGAT-Cre and Scn1a
ﬂ/ﬂ,VGAT-Cre mice. Note that all Scn1aﬂ/ﬂ,VGAT-Cre mice died before P15, and that all but one
Scn1a
ﬂ/+,VGAT-Cre mice died before P35. (G) Veriﬁcation of VGAT-Cre-dependent Scn1a gene deletion in the ﬂoxed allele in P12.5 Scn1a
ﬂ/ﬂ,VGAT-Cre brain
by PCR analysis. (H and I) Veriﬁcation of VGAT-Cre-dependent Nav1.1 deletion by semi-quantitative western blot analysis of brain membrane proteins prepared
fromP12.5Scn1a
ﬂ/ﬂ,VGAT-Cremiceandage-matchedScn1a
ﬂ/ﬂcontrols,usinganti-Nav1.1antibody.Twoindependentassayswereperformed.Errorbarsrepresent
SEM. ∗P , 0.05, ∗∗P , 0.01. +, wild-type allele; ﬂ, ﬂoxed allele; d, deleted allele.
4788 Human Molecular Genetics, 2013, Vol. 22, No. 23neuronal subpopulation with large Nav1.1-immunopositive
somata (Fig. 6Cb). These Nav1.1-immunoreactive downward
basal neurites were not observed in other neocortical layers. In
contrast,inScn1a
ﬂ/ﬂ,Emx1-Cremice,Nav1.1immunoreactivity
was occasionally detected in upward, but rarely in downward,
neurites (Fig. 6Db). These observations suggest that cells with
Nav1.1-positivedownwardbasalneuritesareexcitatorypyram-
idal neurons. Therefore, we performed double-immunolabeling
ofneocorticesinGad67-GFPmice,expressingGFPinglobalin-
hibitory neurons (29), using anti-Nav1.1 and -GFP antibodies.
We detected Nav1.1 immunoreactivity in proximal neurites of
neocortical GFP-positive cells, as well as basal proximal neur-
ites of a subpopulation of layer V GFP-negative cells with rela-
tivelylargepyramidal-shapedsomata(SupplementaryMaterial,
Fig. S2). These observations suggest that in the neocortex,
Nav1.1 is expressed in axons and somata of a subpopulation of
layer V pyramidal excitatory neurons, in addition to PV inhibi-
tory neurons.
Atpostnatalweek8,differencesinNav1.1immunoreactivityin
the hippocampus and neocortex of Scn1a
ﬂ/ﬂ and Scn1a
ﬂ/ﬂ,
Emx1-Cremicebecamemoreapparent(Fig.6E–J).Inthehippo-
campus of Scn1a
ﬂ/ﬂ mice, we observed a band of diffuse Nav1.1
immunoreactivity extending from the stratum lacunosum-
moleculare within the CA ﬁelds to the dentate gyrus molecular
layer (Fig. 6Ea), which would correspond to perforant path
ﬁbers arising from excitatory neurons of the entorhinal cortex,
crossing the stratum lacunosum-moleculare in the hippocampal
CA1ﬁeldandterminatinginthelacunosum-moleculareinthehip-
pocampal CA3 ﬁeld or molecular layer of the dentate gyrus
(30,31). As the middle one-third of the dentate gyrus molecular
Figure 4. Nav1.1 immunosignals are signiﬁcantly reduced in inhibitory neurons of Scn1a
ﬂ/ﬂ,VGAT-Cre mice. (A–D) Representative parasagittal sections of P12.5
Scn1a
ﬂ/ﬂ (A)and Scn1a
ﬂ/ﬂ,VGAT-Cre(B)hippocampi,and P12.5Scn1a
ﬂ/ﬂ (C)andScn1a
ﬂ/ﬂ,VGAT-Cre(D)neocortices,stainedwithanti-Nav1.1 antibody.Higher
magniﬁcation images outlined in (a) are shown in (b). An arrowhead indicates an Nav1.1-immunoreactive proximal neurite oriented toward pial surface, which
putativelycorrespondstoanAISofaPVcell(15,36)(seealsoFig.9O).Scalebars:(a)400 mm;(b)40 mm.DG,dentategyrus;o,stratumoriens;p,stratumpyramidale;
l,stratumlucidum.(EandF)RepresentativeparasagittalsectionsofP12.5Scn1a
ﬂ/ﬂ(E)andScn1a
ﬂ/ﬂ,VGAT-Cre(F)cerebellumstainedwithanti-Nav1.1antibody.
Higher magniﬁcation images outlined in (a) are shown in (b) and (d). Higher magniﬁcation images outlined in (b) are shown in (c). Arrowheads indicate putative
Nav1.1-immunoreactive AISs in Purkinje cells. Arrows indicate Nav1.1-immunoreactive axons of basket cells. Scale bars: (a) 400 mm; (b and c) 40 mm;
(d) 80 mm. M, molecular cell layer; P, Purkinje cell layer; G, granule cell layer; CbN, cerebellar nuclei. Nuclear immunosignals are non-speciﬁc (15). Images are
oriented from the pial surface (top) to the callosal (bottom), and from rostral (left) to caudal (right). ﬂ, ﬂoxed allele.
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ﬂ/ﬂ controls was clearly Nav1.1-immunoreactive,
excitatoryneuronsinthemedial(ratherthanthelateral)entorhinal
cortex appear to express Nav1.1 in their perforant afferents
(31,32). In Scn1a
ﬂ/ﬂ, Emx1-Cre mice, Nav1.1 immunoreactivity
in the perforant path was reduced compared with Scn1a
fl/fl con-
trols (Fig. 6Fa), whereas Nav1.1 signals in axon arborizations of
PV basket cells were largely maintained (Fig. 6Eb and Fb).
These observations, together withthe occurrence of Cre-loxP re-
combination in excitatory neurons in the entorhinal cortex in the
Emx1-Credriverline(26),suggestNav1.1isexpressedintheper-
forant path of medial entorhinal cortex excitatory neurons.
Previous studies have shown that hippocampal pyramidal
cells and dentate gyrus granule cells express Nav1.1 in their
somata and dendrites (14,18,33,34). In contrast, other studies
failed to detect Nav1.1 in somata and proximal neurites of
most, if not all, hippocampal and dentate gyrus excitatory cells
(15,35–37). In agreement with the latter studies, our immuno-
histochemical analysis also failed to detect any distinctive
Nav1.1 immunoreactivity in somata and proximal neurites of
hippocampal and dentate gyrus excitatory neurons in Scn1a
ﬂ/ﬂ
mice (Fig. 6A and E), even when compared with Scn1a
ﬂ/ﬂ,
Emx1-Cre mice (Fig. 6B and F).
Intheneocortexatpostnatalweek8,diffuseNav1.1immunor-
eactivity inlayers II/IIIandVwas lowerinScn1a
ﬂ/ﬂ,Emx1-Cre
mice (Fig. 6H), compared with Scn1a
ﬂ/ﬂ controls (Fig. 6G).
Nav1.1-immunoreactive AIS-like ﬁbers were not found in any
neocortical layers from either genotype. Axons of excitatory
neurons in neocortical layers II/III and V arborize in layers
II/III and V (38–40); therefore, our results may suggest these
axonal arborizations express Nav1.1.
Wealsoperformedimmunohistochemicalanalysisoncoronal
brain sections of 8-week-old Scn1a
ﬂ/ﬂ and Scn1a
ﬂ/ﬂ, Emx1-Cre
mice (Fig. 6I and J). Diffuse Nav1.1 immunoreactivity in the
corpus callosum was observed in Scn1a
ﬂ/ﬂ controls and was
reduced in Scn1a
ﬂ/ﬂ, Emx1-Cre mice, suggesting that Nav1.1
is expressed in callosal axons of neocortical excitatory
neurons.InScn1a
ﬂ/ﬂmice,wealsodetectedcolumnarstructures
ofdiffuseNav1.1immunosignalinlayerIVandattheboundary
betweenlayersVandVI,inbarrelﬁeldsofsomatosensorycortex
(Fig.6Ib),whereaxonsofthalamo-corticalexcitatoryprojection
neurons arborize (41), suggesting Nav1.1 localizes in these
axonal arborizations. In Scn1a
ﬂ/ﬂ, Emx1-Cre mice, diffuse
Nav1.1 immunoreactivites in neocortical layers II/III and V
were reduced, yet the distinctive Nav1.1-immunoreactive col-
umnarstructuresstilldetected(Fig.6Jb),consistentwiththepre-
vious observation that no Cre-loxP recombination was detected
in thalamo-cortical neurons in the Emx1-Cre driver line (26).
Additional Nav1.1 deletion in excitatory neurons of mice
with Nav1.1 haploinsufﬁciency in global inhibitory neurons
ameliorates seizure-related sudden death
It was surprising that Scn1a
ﬂ/+,VGAT-Cre mice show a greater
premature mortality rate than constitutional heterozygous
Scn1a knock-out mice (for a comparison, see Figs 1F and 3F),
raising the possibility that remaining Nav1.1 in excitatory
neurons of Scn1a
ﬂ/+,VGAT-Cre mice may have aggravating
effects on seizure-related sudden death. In order to investigate
this possibility, we generated triple-heterozygous (Scn1a
ﬂ/+,
Emx1-Cre,VGAT-Cre) mice. Like Scn1a
ﬂ/+, VGAT-Cre mice,
Scn1a
ﬂ/+, Emx1-Cre,VGAT-Cre mice were viable until the end
of the second postnatal week, developing convulsive seizures
in the third postnatal week. Importantly, however, the
Figure5.SelectiveNav1.1deletioninforebrainexcitatoryneuronsbyEmx1-Crerecombinationdidnotcauseanyobservableabnormalityinmice.(A)Veriﬁcationof
Emx1-Cre-dependentdeletionoftheﬂoxedScn1ageneinthe8-week-oldScn1a
ﬂ/ﬂ,Emx1-CrebrainbyPCRanalysis.(BandC)VeriﬁcationofEmx1-Cre-dependent
Nav1.1 deletion by semi-quantitative western blot analysis of brain membrane proteins prepared from P21.5 and 8-week-old Scn1a
ﬂ/ﬂ, Emx1-Cre and Scn1a
ﬂ/ﬂ lit-
termates,usinganti-Nav1.1antibody.(D)SurvivalcurvesofP3Scn1a
ﬂ/ﬂandScn1a
ﬂ/ﬂ,Emx1-Crelittermates.Inbothgenotypes,afewmicediedofunknownreasons.
+, wild-type allele; ﬂ, ﬂoxed allele. ∗P , 0.05, ∗∗∗P , 0.001.
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ﬂ/+, Emx1-Cre,VGAT-Cre
mice (15 of 38; 39.5%) was much lower than Scn1a
ﬂ/+,
VGAT-Cre mice (40 of 41; 97.7%), and similar to the rate in
Scn1a
d/+ mice (8 of 36; 22.2%) (Fig. 7). This suggests
that Nav1.1 haploinsufﬁciency in Emx1-lineage forebrain
excitatory neurons reduces the risk of seizure-related sudden
death.
Selective Nav1.1 deletion in PV cells causes spontaneous
epileptic seizures and ataxia in mice
ToselectivelydeleteNav1.1inPVcells,weemployedaPV-Cre
driver line, Pvalb-Cre BAC transgenic (PV-Cre-TG) mice, in
which Cre-loxP recombination occurs in the majority of PV
cells (42). PCR analysis of DNA from Scn1a
ﬂ/ﬂ, PV-Cre-TG
Figure 6. Nav1.1 immunosignals in forebrain excitatory neurons are reduced in Scn1a
ﬂ/ﬂ, Emx1-Cre mice. (A and B) Representative parasagittal sections of P21.5
Scn1a
ﬂ/ﬂ(A)andScn1a
ﬂ/ﬂ,Emx1-Cre(B)hippocampistainedwithanti-Nav1.1antibody.Highermagniﬁcationimagesoutlinedin(a)areshownin(b).Scalebars:(a)
400 mm;(b)40 mm.DG,dentategyrus;o,stratumoriens;p,stratumpyramidale;l,stratumlucidum.(CandD)RepresentativeparasagittalsectionsofP21.5Scn1a
ﬂ/ﬂ
(C)andScn1a
ﬂ/ﬂ,Emx1-Cre(D)neocortices,stainedwithanti-Nav1.1antibody.Highermagniﬁcationimagesoutlinedin(a)areshownin(b).Scalebars:(a)400 mm;
(b)40 mm.ArrowsindicateNav1.1-immunoreactiveneuritesorientedtowardthepialsurface,whichputativelycorrespondtoAISsofneocorticalPVcells(15,36)(see
also Fig. 9O). Double arrowheads indicate Nav1.1-immunoreactive proximalneurites oriented toward the ventricular surface in neocorticallayer V. (E–H) Repre-
sentativeparasagittalsections of 8-week-oldScn1a
ﬂ/ﬂ (E) and Scn1a
ﬂ/ﬂ, Emx1-Cre (F)hippocampi,and 8-week-oldScn1a
ﬂ/ﬂ (G) and Scn1a
ﬂ/ﬂ, Emx1-Cre (H) neo-
cortices, stained with anti-Nav1.1 antibody. Higher magniﬁcation images outlined in (a) are shown in (b). Scale bars: (a) 400 mm; (b) 40 mm. Arrowheads indicate
the Nav1.1-immunoreactive bands extending from the stratum lacunosum-moleculare within the CA ﬁelds to the molecular layer of dentate gyrus, which virtually
correspond to the hippocampal perforant path. DG, dentate gyrus; o, stratum oriens; p, stratum pyramidale; l, stratum lucidum; r, stratum radiatum; lm, stratum
lacunosum-moleculare; m, dentate gyrus molecular layer; g, dentate gyrus granule cell layer. (I and J) Representative coronal sections of 8-week-old Scn1a
ﬂ/ﬂ (I)
and Scn1a
ﬂ/ﬂ, Emx1-Cre (J) brains stained with anti-Nav1.1 antibody (n ¼ 3 per genotype). Arrowheads and arrows indicate the Nav1.1-immunoreactive bands,
whichcorrespondtohippocampalperforantpathandcorpuscallosum,respectively.Highermagniﬁcationimagesoutlinedin(a)areshownin(b).Notethatreductions
in Nav1.1 immunostaining intensities in the medial perforant pathway, corpus callosum and neocortical layers II/III, V and VI in Scn1a
ﬂ/ﬂ, Emx1-Cre mice were
observed in comparison with Scn1a
ﬂ/ﬂ controls. CC, corpus callosum; DG, dentate gyrus; S1BF, primary somatosensory cortex, barrel ﬁeld. Scale bars: 100 mm.
Nuclear immunosignals are non-speciﬁc (15). Parasagittal images are oriented from the pial surface (top) to the callosal (bottom), and from rostral (left) to caudal
(right). Coronal images are oriented from lateral (left) to medial (right). ﬂ, ﬂoxed allele.
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the ﬂoxed Scn1a allele (Fig. 8A). Western blot analysis
showed that Nav1.1 expression in P21.5 Scn1a
ﬂ/ﬂ,PV-Cre-TG
whole brain was reduced to 51.4+2.1% level of that in
Scn1a
ﬂ/ﬂ littermates (Fig. 8B and C). Homozygotes (Scn1a
ﬂ/ﬂ,
PV-Cre-TG) were viable with no obvious abnormal phenotypes
in the ﬁrst postnatal week. However, they developed ataxia and
spontaneous generalized convulsive seizures around P10 and
P14, respectively (Fig. 8D and E), and all died before P30
(Fig. 8F). Heterozygotes (Scn1a
ﬂ/+,PV-Cre-TG) were viable
until the second postnatal week, but some developed recurrent
seizures and suffered sporadic sudden death after P16
(Fig.8F).Thus,thephenotypesofhomozygoteandheterozygote
mice are similar to, or even milder (for example, showing
delayedseizureonset)than,thoseofpreviouslyreportedconsti-
tutionalNav1.1-homozygousandheterozygousknock-outmice,
respectively (14,15).
Immunohistochemical analysisonthe hippocampusandneo-
cortex of Scn1a
ﬂ/ﬂ,PV-Cre-TG and Scn1a
ﬂ/ﬂ mice at P12.5
(before the development of epileptic seizures in Scn1a
ﬂ/
ﬂ,PV-Cre-TG mice) detected weak Nav1.1 immunoreactivities
onﬁbersandpuncta,scatteredwithinthestratumoriens,pyrami-
dale and radiatum of hippocampal CA ﬁelds, as well as in neo-
cortical layers II/III, IV, V and VI. The patterns and intensities
oftheantibodysignalsshowednoobviousgenotypedifferences
(Fig. 9A–D), and provide a likely explanation for the lack of
seizure development in Scn1a
ﬂ/ﬂ,PV-Cre-TG, compared with
Scn1a
d/d mice, at this developmental stage. It also suggests
that transgenic PV promoter-driven Cre-loxP recombination in
the hippocampus and neocortex scarcely occurs at P12.5, con-
sistent withpreviousreportsthatPVexpressioninhippocampal
and neocortical cells begins in the second and third postnatal
weeks (43–45).
At P16.5, when seizures begin in Scn1a
ﬂ/ﬂ,PV-Cre-TG mice,
intensities of hippocampal Nav1.1 immunosignals appeared
moderately reduced in Scn1a
ﬂ/ﬂ,PV-Cre-TG mice, compared
with age-matched Scn1a
ﬂ/ﬂ mice (Fig. 9E and F). In contrast,
neocortical Nav1.1 immunostaining intensities and patterns
remained similar between genotypes (Fig. 9G and H).
At P21.5, when Scn1a
ﬂ/ﬂ,PV-Cre-TG mice suffer recurrent
seizures and sporadic sudden death, genotype differences in
Nav1.1 immunostaining patterns and intensities in the
Fig. 6 Continued
4792 Human Molecular Genetics, 2013, Vol. 22, No. 23hippocampusandneocortexbecamemoreapparent(Fig.9I–L).
In the hippocampus, Nav1.1-immunoreactive ﬁbers and puncta
inCAﬁelds,presumablyaxonsofPVbasketcells,werestrongly
detectedinScn1a
ﬂ/ﬂ,butalmostabsentinScn1a
ﬂ/ﬂ,PV-Cre-TG
mice(Fig.9IandJ).Intheneocortex,Nav1.1immunoreactivity
wasoftenlocalizedinneuritesorientedtowardthepialsurfacein
Scn1a
ﬂ/ﬂmice,butthislocalizationwasnotdistinctlydetectedin
Scn1a
ﬂ/ﬂ, PV-Cre-TG mice (Fig. 9K–N), providing further evi-
dencethatneocorticalPVcellsexpressNav1.1(15).Incontrast,
ﬁbrous Nav1.1 immunoreactivity was occasionally detected in
downward projecting basal neurites of layer V cells in both
Scn1a
ﬂ/ﬂ and Scn1a
ﬂ/ﬂ, PV-Cre-TG mice (Fig. 9M and N).
Taken together with ourobservationsthat downwardprojecting
basal neurites with Nav1.1 immunoreactivity were rarely
observed in Scn1a
ﬂ/ﬂ, Emx1-Cre mice (see Fig. 6Db), Nav1.1
appears to be expressed in a subset of neocortical layer V
PV-negative, excitatory pyramidal neurons, consistent with
recent studies (18,19). It is notable that the diffuse background-
like signal, presumably a signal in distal axons of excitatory
neurons (see also Fig. 6I and J), remained high, or became
even higher, in both genotypes compared with those at P16.5.
In addition, Nav1.1 immunoreactivities at neocortical layer IV,
and between layers V and VI, reﬂecting signals in arborized
axons of thalamo-cortical projection neurons (41), and reported
as PV-positive (42), were moderately reduced in Scn1a
ﬂ/ﬂ,
PV-Cre-TGmice,comparedwithScn1a
ﬂ/ﬂmice(Fig.9KaandLa).
Immunoﬂuorescent examination of Nav1.1 colocalization
with PV and ankyrin-G, a marker for AISs, in P21.5 Scn1a
ﬂ/ﬂ
controls, conﬁrmed marked Nav1.1 immunopositivity in AISs
of neocortical PV cells (Fig. 9O), reported previously at
P14–16 (15). In contrast, a signiﬁcant reduction in Nav1.1
immunostaining intensities was observed in AISs of most neo-
cortical PV cells in P21.5 Scn1a
ﬂ/ﬂ, PV-Cre-TG mice (Fig. 9P).
Figure 7. Additional Emx1-Cre-mediated Nav1.1 deletion in Scn1a
ﬂ/+,
VGAT-Cre mice ameliorates seizure-related sudden death. Survival curves of
P3 Scn1a
ﬂ/+, Scn1a
ﬂ/+, Emx1-Cre, Scn1a
ﬂ/+, Emx1-Cre,VGAT-Cre and
Scn1a
ﬂ/+, VGAT-Cre littermates. Survival curve of Scn1a
d/+ (reprinted from
Fig.1F)isincludedforcomparison.Notethatasigniﬁcantdecreaseinpremature
lethality in Scn1a
ﬂ/+, Emx1-Cre,VGAT-Cre mice was observed in comparison
with Scn1a
ﬂ/+, VGAT-Cre mice. +, wild-type allele; ﬂ, ﬂoxed allele.
Figure 8. Selective Nav1.1 deletion in mouse PV cells by PV-Cre causes spontaneous epileptic seizures and premature death. (A) Veriﬁcation of
PV-Cre-TG-dependentﬂoxedScn1agenedeletioninthebrainbyPCRanalysis.(BandC)VeriﬁcationofPV-Cre-TG-dependentNav1.1deletionbysemi-quantitative
westernblotanalysisonbrainmembraneproteinspreparedfromP21.5Scn1a
ﬂ/ﬂ,PV-Cre-TGandScn1a
ﬂ/ﬂlittermates,usinganti-Nav1.1antibody.Errorbarsrepre-
sentSEM;twoindependentassayswereperformed.(DandE)Representativeinterictal(D)andictal(E)ECoGrecordingsinP14–16Scn1a
ﬂ/ﬂ,PV-Cre-TGmiceand
Scn1a
ﬂ/ﬂ control mice (n ¼ 3, each group). (F) Survival curves of P3 Scn1a
ﬂ/ﬂ, Scn1a
ﬂ/+, Scn1a
ﬂ/+, PV-Cre-TG and Scn1a
ﬂ/ﬂ,PV-Cre-TG littermates. Note that all
Scn1a
ﬂ/ﬂ, PV-Cre-TG mice died before P25. +, wild-type allele; ﬂ, ﬂoxed allele. ∗∗∗P , 0.001.
Human Molecular Genetics, 2013, Vol. 22, No. 23 4793Figure9.Nav1.1immunosignalsinPVinhibitoryneuronsarereducedatlaterdevelopmentalstagesinScn1a
ﬂ/ﬂ,PV-TG-Cremice.(A–N)Representativeparasagittal
sections of P12.5 Scn1a
ﬂ/ﬂ (A) and Scn1a
ﬂ/ﬂ, PV-Cre-TG (B) hippocampi, P12.5 Scn1a
ﬂ/ﬂ (C) and Scn1a
ﬂ/ﬂ, PV-Cre-TG (D) neocortices, P16.5 Scn1a
ﬂ/ﬂ (E) and
Scn1a
ﬂ/ﬂ, PV-Cre-TG (F) hippocampi, P16.5 Scn1a
ﬂ/ﬂ (G) and Scn1a
ﬂ/ﬂ, PV-Cre-TG (H) neocortices, P21.5 Scn1a
ﬂ/ﬂ (I) and Scn1a
ﬂ/ﬂ, PV-Cre-TG (J) hippocampi
and P21.5 Scn1a
ﬂ/ﬂ (K and M) and Scn1a
ﬂ/ﬂ, PV-Cre-TG (L and N) neocortices, stained with anti-Nav1.1 antibody. P21.5 was the oldest age used for analysis as
Scn1a
ﬂ/ﬂ, PV-TG-Cre mice show a high mortality rate beyond P15 and a life expectancy within P30. Higher magniﬁcation images outlined in (a) are shown in
(b). Arrowheads indicate putative Nav1.1-immunoreactive AISs of neocortical PV cells. Double arrowheads indicate Nav1.1-immunoreactive proximal neurites
oriented toward the ventricular surface. Scale bars: (a) 400 mm; (b) 40 mm. DG, dentate gyrus; o, stratum oriens; p, stratum pyramidale; l, stratum lucidum.
(O and P) Immunoﬂuorescence histochemistry of neocortices of P21.5 Scn1a
ﬂ/ﬂ (O) and Scn1a
ﬂ/ﬂ, PV-TG-Cre (P) mice stained with anti-Nav1.1 (a; red), PV
(b; green) and ankyrin G (c; cyan) antibodies and counterstained with DAPI (d; blue). Merged images are shown (e). Arrowheads indicate AISs of neocortical PV
cells with strong Nav1.1 immunoﬂuorescence. An arrow indicates an AIS of a PV cell with reduced Nav1.1 immunoﬂuorescence. Scale bars: 100 mm. (Q and R)
Representative parasagittal sections of P12.5 Scn1a
ﬂ/ﬂ (Q) and Scn1a
ﬂ/ﬂ, PV-TG-Cre (R) cerebellum stained with anti-Nav1.1 antibody. Higher magniﬁcation
images outlined in (a) are shown in (b) and (d). Higher magniﬁcation images outlined in (b) are shown in (c). Scale bars: (a) 400 mm; (b and c) 40 mm; (d) 80 mm.
Arrowheads and arrows indicate Nav1.1-immunoreactive AISs of Purkinje cells and axons of basket cells, respectively. M, molecular cell layer; P, Purkinje cell
layer; G, granule cell layer; CbN, cerebellar nuclei. Nuclear immunosignals are non-speciﬁc (15). Images are oriented from the pial surface (top) to the callosal
(bottom), and from rostral (left) to caudal (right). ﬂ, ﬂoxed allele.
4794 Human Molecular Genetics, 2013, Vol. 22, No. 23In the cerebellum at P12.5, when Scn1a
ﬂ/ﬂ, PV-Cre-TG mice
suffer severe ataxia, differences in Nav1.1 immunostaining pat-
ternsandintensitieswereobservedbetweenScn1a
ﬂ/ﬂandScn1a
ﬂ/ﬂ,
PV-Cre-TG mice (Fig. 9Q and R). Nav1.1-immunoreactive ﬁbers
and puncta distributed in the inner molecular layer of cerebellar
lobes, presumably corresponding to PV-expressing cerebellar
basketcells(15,46),wereclearlyobservedinScn1a
ﬂ/ﬂ,butvirtually
undetectable in Scn1a
ﬂ/ﬂ, PV-Cre-TG mice (Fig. 9Qa–c and Ra–
c). Similarly, immunoreactivities in AISs of Purkinje cells were
observed in Scn1a
ﬂ/ﬂ mice, as previously reported (15), but not in
Scn1a
ﬂ/ﬂ, PV-Cre-TG mice (Fig. 9Qc and Rc). Intensities of
Nav1.1 immunoreactivities on puncta scattered within cerebellar
nucleiandwhitematter,comprisingprojectingaxonsfromcerebel-
larPurkinjecells(47),werereducedinScn1a
ﬂ/ﬂ,PV-Cre-TGmice,
compared with Scn1a
ﬂ/ﬂ mice (Fig. 9Qd and Rd).
We also crossed ﬂoxed Scn1a mice with Pvalb-Cre knock-in
(PV-Cre-KI) mice (48), in which the PV-Cre knock-in allele
harborsaninternalribosomeentrysite(IRES)andCrerecombin-
aseinsertsintothe3′ UTRofthemousePvalbgene.Endogenous
Pvalb promoter-driven Cre-loxP recombination occurs only
Fig. 9 Continued
Human Molecular Genetics, 2013, Vol. 22, No. 23 4795withinPVinhibitoryneurons,withhighPVexpressionsuggesting
low recombination efﬁciency (49–51).
PCRanalysisofDNAfromScn1a
ﬂ/ﬂ,PV-Cre-KIwholebrain
veriﬁed PV-Cre-KI-dependent recombination of the ﬂoxed
Scn1a allele (Fig. 10A). Western blot analysis showed that
Nav1.1 expression levels in Scn1a
ﬂ/ﬂ, PV-Cre-KI mouse
whole brain at P21.5 and 8 weeks were 98.9+6.4 and 87.6+
4.3% of those in age-matched Scn1a
ﬂ/ﬂ control littermates, re-
spectively,althoughtheslightreductionat8weekswasnotstat-
isticallysigniﬁcant(Fig.10BandC).Scn1a
ﬂ/ﬂ,PV-Cre-KImice
were viable with no obvious abnormal phenotypes until the be-
ginningofthethirdpostnatalweek.Themicedevelopedspontan-
eous recurrent convulsive seizures with abnormal ECoG patterns
aroundP20(Fig.10DandE).Inaddition,themiceexhibitedabnor-
mal interictal poly-spike-wave discharges, which were most pro-
nounced during resting or sleeping (Fig. 10F). At around P20,
Scn1a
ﬂ/ﬂ, PV-Cre-KI mice developed ataxia, which was clearly
observed in inclined (an  458 angle) cages. Scn1a
ﬂ/ﬂ mice
walked up and down the slope with a steady gait; however, in
contrast, although Scn1a
ﬂ/ﬂ, PV-Cre-KI mice were able to climb
up the slope, they always slipped down the slope with an unstable
gait. Some Scn1a
ﬂ/ﬂ, PV-Cre-KI mice suffered sporadic sudden
d e a t ha f t e rP 2 5( F i g .10G). These results suggest that a minimal
amount of Nav1.1 deletion, speciﬁcally in PV cells, is enough to
cause spontaneous epileptic seizures, ataxia and occasional
sudden death.
The spatial and temporal patterns of Nav1.1 expression were
examined by immunohistochemistry in Scn1a
ﬂ/ﬂ, PV-Cre-KI
brain parasagittal sections. At P16.5, before Scn1a
ﬂ/ﬂ, PV-Cre-
KI mice developed epileptic seizures, Nav1.1 immunostaining in-
tensities and patterns in the hippocampus and neocortex of
Scn1a
ﬂ/ﬂ, PV-Cre-KI mice were similar to those in age-matched
Scn1a
ﬂ/ﬂ controls (Fig. 11A–D). This is in agreement with late
onset of endogenous PV promoter-driven Cre-loxP recombination
inthehippocampusandneocortex(52),andprovidesaplausible
explanationforthelackofseizuresinScn1a
ﬂ/ﬂ,PV-Cre-KImice
atthispostnatalstage,despiteScn1a
d/dmiceofthesameagesuf-
fering recurrent seizures (see Fig. 1D and E). In Scn1a
ﬂ/ﬂ mice,
Figure10.MinimalselectiveNav1.1deletioninPVcellsbylow-efﬁciencyPV-Crerecombinationissufﬁcienttocausespontaneousepilepticseizuresandoccasional
prematuredeathinmice.(A)VeriﬁcationofPV-Cre-KI-dependentﬂoxedScn1agenedeletioninScn1a
ﬂ/ﬂ,PV-Cre-KIbrainbyPCRanalysis.(BandC)Veriﬁcation
of PV-Cre-KI-dependent Nav1.1 deletion by semi-quantitative western blot analysis of brain membrane proteins prepared from P21.5 and 8-week-old Scn1a
ﬂ/ﬂ,
PV-Cre-KI and Scn1a
ﬂ/ﬂ littermates, using anti-Nav1.1 antibody (B). Mean Nav1.1 expression levels in Scn1a
ﬂ/ﬂ, PV-Cre-KI mice are represented as percentages
relative to Scn1a
ﬂ/ﬂ mice (100%) (C). Error bars represent SEM; two independent assays were performed. (D–F) Spontaneous epileptic seizures in Scn1a
ﬂ/ﬂ,
PV-Cre-KImice.Representativenormalinterictal(D),ictal(E)andabnormalinterictal(F)ECoGsrecordedinScn1a
ﬂ/ﬂ,PV-Cre-KImiceareshown.ECoGrecordings
were performed with P25–30 Scn1a
ﬂ/ﬂ, PV-Cre-KI and Scn1a
ﬂ/ﬂ control mice. (G) Survival curves of P3 Scn1a
ﬂ/ﬂ, Scn1a
ﬂ/+, Scn1a
ﬂ/+, PV-Cre-KI and Scn1a
ﬂ/ﬂ,
PV-Cre-KI littermates. A proportion of Scn1a
ﬂ/ﬂ, PV-Cre-KI mice suffered sporadic death after P25. +, wild-type allele; ﬂ, ﬂoxed allele.
4796 Human Molecular Genetics, 2013, Vol. 22, No. 23Figure11.Nav1.1immunosignalsinPVinhibitoryneuronsaremoderatelyreducedatlaterdevelopmentalstagesinScn1a
ﬂ/ﬂ,PV-KI-Cremice.(A–L)Representative
parasagittalsectionsofP16.5Scn1a
ﬂ/ﬂ(A)andScn1a
ﬂ/ﬂ,PV-Cre-KI(B)hippocampi,P16.5Scn1a
ﬂ/ﬂ(C)andScn1a
ﬂ/ﬂ,PV-Cre-KI(D)neocortices,P21.5Scn1a
ﬂ/ﬂ
(E) and Scn1a
ﬂ/ﬂ, PV-Cre-KI (F) hippocampi, P21.5 Scn1a
ﬂ/ﬂ (G) and Scn1a
ﬂ/ﬂ, PV-Cre-KI (H) neocortices, 8-week-old Scn1a
ﬂ/ﬂ (I) and Scn1a
ﬂ/ﬂ, PV-Cre-KI (J)
hippocampi and 8-week-old Scn1a
ﬂ/ﬂ (K) and Scn1a
ﬂ/ﬂ, PV-Cre-KI (L) neocortices, stained with anti-Nav1.1 antibody. Higher magniﬁcation images outlined in
(a)are shownin(b).Scalebars:(a)400 mm;(b)40 mm.ArrowheadsanddoublearrowheadsindicateNav1.1-immunoreactiveAISsofneocorticalPVcellsandhip-
pocampal perforant path afferents, respectively. DG, dentate gyrus; o, stratum oriens; p, stratum pyramidale; l, stratum lucidum; r, stratum radiatum; lm, stratum
lacunosum-moleculare; m, dentate gyrus molecular layer; g, dentate gyrus granule cell layer. (M and N) Representative parasagittal sections of P21.5 Scn1a
ﬂ/ﬂ
(M)andScn1a
ﬂ/ﬂ,PV-Cre-KI(N)cerebellum,stainedwithanti-Nav1.1antibody.Highermagniﬁcationimagesoutlinedin(a)areshownin(b)and(d).Highermag-
niﬁcationimagesoutlinedin(b)areshownin(c).ArrowsindicateputativeNav1.1-immunoreactiveaxonsofbasketcells.Scalebars:(a)400 mm;(bandc)40 mm;(d)
80 mm.M,molecularcelllayer;P,Purkinjecelllayer;G,granulecelllayer;CbN,cerebellarnuclei.NuclearNav1.1immunostainingisnon-speciﬁc(15).Imagesare
oriented from the pial surface (top) to the callosal (bottom), and from rostral (left) to caudal (right). ﬂ, ﬂoxed allele.
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of neocortical PV cells that often oriented toward the pial
surface, as previously described (15,36) (see also Fig. 9O).
AtP21.5,whenScn1a
ﬂ/ﬂ,PV-Cre-KImicebegantosufferre-
currentseizures,Nav1.1-immunoreactiveﬁbersinhippocampal
CA ﬁelds, presumably axons of PV-positive fast-spiking basket
cells (15), were observed in Scn1a
ﬂ/ﬂ mice (Fig. 11E), but
reduced inScn1a
ﬂ/ﬂ, PV-Cre-KI mice (Fig. 11F). This is consist-
ent withNav1.1 localization in axons of hippocampal PV inhibi-
toryneuronswithinthestratumoriensandpyramidale(53–55)in
wild-type mice (15,37). In contrast, staining intensities and pat-
terns in Nav1.1-immunoreactive ﬁbers and puncta scattered
within the neocortex appeared similar between genotypes at this
stage (Fig. 11G and H), suggesting that modest reductions in
Nav1.1expressionlevelsinhippocampalPVinterneuronsaresuf-
ﬁcient to cause epileptic seizures in mouse.
At postnatal week 8, differences in Nav1.1 immunostaining
patterns in the hippocampus of Scn1a
ﬂ/ﬂ, PV-Cre-KI and
Scn1a
ﬂ/ﬂ mice became more evident (Fig. 11I and J). Nav1.1-
immunoreactive ﬁbers and puncta scattered in hippocampal CA
ﬁelds were observed in Scn1a
ﬂ/ﬂ mice, but virtually undetected
in Scn1a
ﬂ/ﬂ, PV-Cre-KI mice. Moreover, the band of diffuse
Nav1.1immunoreactivityextendingfromthestratumlacunosum-
moleculareofhippocampalCAﬁeldstothemolecularlayerofthe
dentategyruswasdetectedsimilarlyinbothgenotypes(Fig.11Ia
andJa).ThesediffuseNav1.1immunoreactivitiesareassumedto
betheperforantpath(30,31)(seealsoFig.6EaandFa).Intheneo-
cortexatpostnatalweek8,overallNav1.1immunostaininginten-
sities appeared subtly decreased in Scn1a
ﬂ/ﬂ, PV-Cre-KI mice,
compared with Scn1a
ﬂ/ﬂ mice (Fig. 11K and L).
InthecerebellumatP21.5,astagewhenScn1a
ﬂ/ﬂ,PV-Cre-KI
mice display ataxia, differences in Nav1.1 immunostaining in-
tensities were observed between Scn1a
ﬂ/ﬂ and Scn1a
ﬂ/ﬂ,
PV-Cre-KI mice (Fig. 11M and N). Nav1.1 immunoreactivities
inﬁbersandpunctadistributedintheinnermolecularlayerofcere-
bellar lobes, putatively corresponding to axons of PV-expressing
cerebellar basket cells (15,46), appeared weaker in Scn1a
ﬂ/ﬂ,
PV-Cre-KI mice than in Scn1a
ﬂ/ﬂ mice (Fig. 11Ma–c and Na–c).
Also, Nav1.1-immunoreactive puncta scattered in cerebellar
nuclei and white matter, comprising PV-expressing cerebellar
Purkinje cells axons (47), appeared reduced in Scn1a
ﬂ/ﬂ,
PV-Cre-KI mice, compared with Scn1a
ﬂ/ﬂ mice (Fig. 11Md and
Nd).
All of the phenotypic and immunohistochemical data on a
series of conditional Scn1a mutant mice obtained in the
present study were summarized in Tables 1 and 2.
DISCUSSION
Our study on a series of conditional Scn1a knock-out mice pro-
videsimportantinsightsintothepathologyofDravetsyndrome.
MicewithselectiveNav1.1deletioninglobalinhibitoryneurons
(using VGAT-Cre recombination) suffered epileptic seizures
with a signiﬁcantly higher risk of lethality than constitutive
Scn1a knock-out mice. Nav1.1 deletion in mouse excitatory
neurons(usingEmx1-Crerecombination)didnotcauseepileptic
seizures or any other observable behavioral abnormalities, but
ameliorated the signiﬁcant lethality of Nav1.1 deletion in
global inhibitory neurons (using combined Emx1-Cre and
VGAT-Cre-dependent recombination) (Tables 1 and 2). These
ﬁndings show for the ﬁrst time the protective or ameliorating
effect of Nav1.1 haploinsufﬁciency in excitatory neurons on
the risk of SUDEP in Dravet syndrome.
Cheah et al.( 19) recently showed inhibitory neuron-speciﬁc
Nav1.1 deletion in mice, using the Dlx1/2-I12b-Cre driver
(Scn1a
ﬂ/+,Dlx-Cre), which caused spontaneous epileptic sei-
zures and premature lethality, although the phenotype of
Scn1a
f/+, Dlx-Cre mice was milder than that of Scn1a
f/+,
VGAT-Cremice,andmorecomparablewithconstitutiveheterozy-
gous Scn1a knock-out mice. Dlx1/2-I12b-Cre expresses Cre re-
combinase in the majority of GABAergic inhibitory neurons,
including PV-, somatostatin-, neuropeptide Y- and calretinin-
positive cells (20). Given that Dlx1/2-I12b-Cre-mediated Nav1.1
deletion occurs in  50% of forebrain inhibitory neurons (19),
phenotypic differences between Scn1a
ﬂ/+, Dlx-Cre and Scn1a
ﬂ/+,
VGAT-Cre miceare likelydue todifferences inNav1.1 deletion
efﬁciencyininhibitoryneurons.Moreover,differencesingenetic
backgrounds (Scn1a
ﬂ/+, Dlx-Cre and Scn1a
ﬂ/+,VGAT-Cre mice
on C57BL/6:CD1 and C57BL/6:129 mixed backgrounds, re-
spectively) may have affected severities of premature lethality
Fig. 11 Continued
4798 Human Molecular Genetics, 2013, Vol. 22, No. 23(14,15). The study on Scn1a
ﬂ/+, Dlx-Cre mice (19) also found
Nav1.1 expression in certain excitatory neurons, including
layer V pyramidal cells; however, they did not discuss a func-
tionalroleofNav1.1inexcitatoryneurons,withregardtoepilep-
tic phenotypes.
Dutton et al.( 18) reported another conditional Nav1.1 inacti-
vation in mice, using the Ppp1r2-Cre driver that preferentially
induces Cre-loxP recombination in a subset of forebrain
GABAergic inhibitory neurons consisting of  75, 30 and 15%
of total PV-, reelin- and neuropeptide Y-positive cells (21).
Scn1a
ﬂ/+,Ppp1r2-Cre mice show increased ﬂurothyl- and
hyperthermia-induced seizure susceptibilities, and develop in-
frequent seizures. However, the mice do have a normal lifespan
andlessspontaneousseizurescomparedwithconstitutiveScn1a
knock-out mice (18). This milder phenotype could be due to
restricted or incomplete Nav1.1 deletion by Ppp1r2-Cre, as dis-
cussed by the authors (18). Dutton et al.( 18) also generated
Scn1a
ﬂ/+, Emx1-Cre mice, reporting that the mice had normal
susceptibilitylevelsofﬂurothyl-andhyperthermia-inducedsei-
zures, not consistent with our observation of an ameliorating
effect of Emx1-Cre-dependent Nav1.1 deletion in Scn1a
ﬂ/+,
VGAT-Cre mice. It is possible that the protective effect of
Nav1.1-haploinsufﬁcient forebrain excitatory neurons is only
observed when seizures are generated spontaneously or in dis-
tinct pathologies, and may partially explain the conﬂicting
results. Alternatively, seizure generation and seizure-related
suddendeathmayinvolvedistinctneuronalcircuitsornetworks.
Further studies are needed to investigate the nature of these
discrepancies.
OurstudyalsoshowedthatminimalPV-positivecell-speciﬁc
Nav1.1deletion,usingPV-Cre-KI,issufﬁcienttocausespontan-
eous epileptic seizures and ataxia in mice (Tables 1 and 2),
further supporting ourpreviousproposal that functional impair-
ment of PV interneurons is the basis for epileptic seizures in
Dravetsyndrome(15).PVhasbeenwidelyusedasaspeciﬁcbio-
chemical marker for a subclass of forebrain GABAergic inhibi-
toryneuronsthatcanalsobegroupedelectro-physiologicallyas
fast-spiking neurons, or morphologically as basket cells and
chandelier cells. In Pvalb-IRES-Cre lines, for example, the
PV-Cre-KImiceusedinourstudy,endogenousPvalbpromoter-
driven Cre-loxP recombination occurs only in subsets of PV
inhibitory neurons expressing high PV levels and with large
somata (49), suggesting incomplete Nav1.1 deletion in PV in-
hibitory neurons of Scn1a
ﬂ/ﬂ, PV-Cre-KI mice. In the
PV-Cre-TG driver line, transgenic Pvalb promoter-driven
Cre-loxP recombination occurs in the majority of PV cells and,
toamuchlesserextent,inPV-negativecells,includingasubpo-
pulation of somatostatin-positive inhibitory neurons (42).
Higher efﬁciency or more widespread occurrence of Cre-loxP
recombination in PV-Cre-TG, than PV-Cre-KI, driver line
likely accounts for the greater amount of PV-Cre-dependent
Nav.1.1 reduction in Scn1a
ﬂ/ﬂ, PV-Cre-TG mice than in
Scn1a
ﬂ/ﬂ, PV-Cre-KI mice (Tables 1 and 2). Differences in
Cre-loxP recombination efﬁciency in PV inhibitory neurons
appear to contribute to differences in phenotypic severity
between Scn1a
ﬂ/ﬂ, PV-Cre-TG and Scn1a
ﬂ/ﬂ, PV-Cre-KI mice.
The phenotypic severity of Scn1a
ﬂ/ﬂ, PV-Cre-TG mice is com-
parable with constitutive Scn1a heterozygous knock-out mice,
but far milder than Scn1a
ﬂ/ﬂ,VGAT-Cre mice (Tables 1 and 2).
Several explanations can account for these differences. First,
the onset of PV expression occurs at a later developmental
stage. In hippocampal and neocortical PV interneurons, PV ex-
pression isdetectable inthe second postnatal week and progres-
sivelyup-regulatedthereafter(43–45;AllenDevelopingMouse
Brain, http://developingmouse.brain-map.org/). Coincident
with the onset and up-regulation of PV expression, Nav1.1 ex-
pression levels in the hippocampus and neocortex of Scn1a
ﬂ/ﬂ,
PV-Cre-TG mice are progressively reduced after the second
postnatal week. Compared with Scn1a
ﬂ/ﬂ, PV-Cre-TG mice,
Scn1a
ﬂ/ﬂ,VGAT-Cre mice had an earlier onset of a reduction
in Nav1.1 expression levels in both the hippocampus and
neocortex, consistent with RNA in situ hybridization data
showing detectable VGAT expression in the forebrain in the
ﬁrst postnatal week, before the onset of PV expression (Allen
Developing Mouse Brain, http://developingmouse.brain-map.
org/). Second, the milder phenotype observed in Scn1a
ﬂ/ﬂ,
PV-Cre-TG mice may be facilitated by the ameliorating effect
ofNav1.1deletioninPV-positiveexcitatoryneurons.Inaddition
toPVinterneurons,PVexpressionisfoundinseveralexcitatory
neuronal subtypes, including a small subpopulation of neocor-
tical layer V excitatory neurons and thalamo-cortical excitatory
projection neurons (42,49,56). Our study shows Nav1.1
Table 1. Summary of phenotypes observed in conditional Scn1a mutant mice generated in this study
Genotype Seizure (onset age) Ataxia (onset age) Average lifespan Under-P35 mortality Genetic background
Cre driver Scn1a alleles C57BL/6:129
(EIIa-Cre)
a d/d GTC ( P12) Severe ( P10) 16.2 days (n ¼ 19) 100% (n ¼ 19) 0.97:0.03
d/+ GTC ( P16) 2 ND 22.2% (n ¼ 36)
VGAT-Cre ﬂ/ﬂ Myoclonus ( P11) 2 12.8 days (n ¼ 4) 100% (n ¼ 4) 0.96:0.04
ﬂ/+ GTC ( P16) 2 ND 98.6% (n ¼ 65) 0.94:0.06
97.7% (n ¼ 41) 0.95:0.05
Emx1-Cre ﬂ/ﬂ 22 ND 15.4% (n ¼ 13) 0.91:0.09
Emx1-Cre, VGAT-Cre ﬂ/+ GTC ( P16) 2 ND 39.5% (n ¼ 38) 0.95:0.05
PV-Cre-TG ﬂ/ﬂ GTC ( P14) Severe ( P10) 21.3 days (n ¼ 17) 100% (n ¼ 17) 0.91:0.09
ﬂ/+ GTC ( P18) 2 ND 3.8% (n ¼ 53)
PV-Cre-KI ﬂ/ﬂ GTC ( P20) Mild ( P20) ND 15.6% (n ¼ 32) 0.91:0.09
ﬂ/+ 22 ND 3.6% (n ¼ 32)
GTC, generalized tonic clonic seizures; 2, not observed; ND, not determined; P, postnatal day; +, wild-type allele; ﬂ, ﬂoxed allele; d, deleted allele.
aEIIa-Cre was removed in Scn1a
d/d and Scn1a
d/+ mice.
Human Molecular Genetics, 2013, Vol. 22, No. 23 4799expression in neocortical layer V excitatory neurons, consistent
with previous studies (18,19), and thalamo-cortical projection
neurons. As discussed, our results with VGAT- and Emx1-
double-CremicesuggestthatNav1.1haploinsufﬁciencyinexci-
tatory pyramidal cells may have an ameliorating effect on sei-
zures. Given that impaired function of thalamo-cortical
projection neurons has a protective inﬂuence on seizure path-
ology (57), Nav1.1 deletion in thalamo-cortical PV projection
neurons may contribute to amelioration of epileptic seizures
and seizure-related lethality in Scn1a
ﬂ/ﬂ, PV-Cre-TG mice.
This possible ameliorating effect of Nav1.1 deletion in thalamo-
corticalPVprojectionneuronscanalsocontributetothebettersur-
vival rate in Scn1a
d/+ mice than in Scn1a
ﬂ/+, Emx1-Cre,
VGAT-Cre mice, in which Nav1.1 expression in thalamo-cortical
projection neurons should remain intact. Third, as suggested
by Dutton et al.( 18), PV-negative interneurons, such as
somatostatin-, calretinin-, reelin- or neuropeptide Y-positive
cells, may express Nav1.1 (18), and Nav1.1 haploinsufﬁciency
in these cells may aggravate epileptic phenotypes in Scn1a
ﬂ/
+,VGAT-Cre mice. A caveat to this is that we did not detect
Nav1.1 expression in PV-negative interneurons by immunohis-
tochemistry.Furtherstudiesarerequiredtodeterminetheroleof
PV-negative interneurons in Dravet syndrome mouse models
and patients.
It has been known that genetic backgrounds largely affect
seizure severity in the mice with Nav1.1 haploinsufﬁciency
(14,15). In our previous study (15), the mixed C57BL6/129
(75%/25%) background resulted in 25% lethality at 1 week of
ageand40%at3 weeks,whereasthe129dominantmixedback-
ground(C57BL6/129 ¼ 25%/75%)didnotleadtoprematurele-
thality. In this study, because all of the conditional knock-out
mouse lines have similar levels of C57BL6/129 (Table 1), con-
tribution of genetic backgrounds to the phenotypic differences
among the conditional lines seems to be minimal.
In summary, the present study showed, for the ﬁrst time, that
Nav1.1haploinsufﬁcienciesinexcitatoryandinhibitoryneurons
are both involved in the pathology of Dravet syndrome. Al-
though therapeutic approaches to compensate for Nav1.1 hap-
loinsufﬁciency are potential treatments for Dravet syndrome,
our results highlight the need for preferential targeting of thera-
peutic approaches to inhibitory, rather than excitatory neurons.
We also show that a minimal amount of Nav1.1 deletion in PV
cells is enough to cause spontaneous epileptic seizures in
mouse,supportingourpreviousproposalthatfunctionalimpair-
ments of PV interneurons are the circuit basis for the epileptic
pathology of Dravet syndrome, and further proposing PV inter-
neurons as promising therapeutic targets.
MATERIALS AND METHODS
Gene targeting and mice
Mice were handled in accordance with the guidelines of the
Animal Experiment Committee of RIKEN Brain Science Insti-
tute and National Institute of Genetics.
The P1-derived artiﬁcial chromosome (PAC) clones (460H9,
569J7 and 306M11) were isolated by screening a pooled mouse
genomic PAC library (BACPAC Resource Center, Oakland,
CA,USA)bydotblothybridizationusingtheprobecorrespond-
ing to the genomic fragment containing the Scn1a coding exon
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the EcoRI site of pBluescript II SK(2) (Agilent Technologies,
Santa Clara, CA, USA) to obtain pE8. A 2.6 kb ApaI and
blunt-ended EcoT22I fragment from pE8 was inserted into
ApaI and blunt-ended SalI sites of ploxPfrtPGKneofrt to gener-
ate pL1. pL1 was then digested with ClaI, ﬁlled with T4 DNA
polymerase and the loxP cassette inserted to yield pL2. pE8
was also digested with SalI and AﬂII, ﬁlled with T4 DNA poly-
meraseandself-ligatedtogeneratepL3.A6.8 kbApaIfragment
of pL3 was inserted into the ApaI site of pL2 to yield pL4. In
order to generate pP8, a 4.6 kb PstI fragment of a PAC clone
was subcloned into the PstI site of pBluescript II SK(2)
(Agilent Technologies). A 3.1 kb PstI and blunt-ended
EcoT22IfragmentofpP8wasinsertedintoPstIandblunt-ended
SalIsitesofpEGFP-C2(TakaraBio,Shiga,Japan)toobtainpR1.
AXhoIfragmentofpMCDTApA(agenerousgiftfromDrYagi,
Osaka University) was then inserted into an SalI site of pR1 to
yield pR2. The targeting vector was generated by inserting the
EagIandSacIIfragmentofpR2intoNotIandSacIIsitesofpL4.
ThetargetingvectorwaslinearizedwithSacIIandtransfected
into129P2/Ola-derivedembryonicstem(ES)cellsusingaGene-
Pulser(Bio-Rad,Hercules,CA,USA)at3 mFand800 V.Trans-
fected ES cells were plated on neomycin-resistant, mitomycin
C-treated mouse embryonic feeder cells (MEF). One day after
plating, positive selection was performed in the presence of
150 mg/ml of Geneticin (G418; Life Technologies, Carlsbad,
CA, USA). Resistant clones were picked at day 7, subsequently
expanded into 24-well plates pre-seeded with MEF, and
screened by Southern blotting (using both 5′ and 3′ probes
located outside the targeting construct) and PCR analysis.
Cells from three independent positive clones (1C12, 6A8 and
6G10) were injected into C57BL/6J blastocysts, which were
transferred into pseudopregnant female recipient ICR mice.
Each ES clone produced male chimeras with .50% agouti
coat color, which were bred to C57BL/6J females to allow for
the detection of germline transmission. F1 mice heterozygous
for the targeted allele were obtained and crossed with
CAG-FLPe deleter mice on a C57BL/6J background (58)t o
obtain N2 mice heterozygous (Scn1a
ﬂ/+,CAG-FLPe) for the
ﬂoxed allele and lacking the neomycin cassette. Absence of
the neo-cassette was veriﬁed by PCR analysis. N2 Scn1a
ﬂ/
+,CAG-FLPe mice were subsequently crossed with C57BL/6J
mice to obtain N3 Scn1a
ﬂ/+ mice without the CAG-FLPe trans-
gene.AbsenceoftheCAG-FLPetransgenewasveriﬁedbyPCR
analysis. Scn1a
ﬂ/+ mice were thereafter maintained by crossing
with C57BL/6J mice. Homozygous (Scn1a
ﬂ/ﬂ) mice were
obtained by interbreeding N3 or N4 Scn1a
ﬂ/+ mice. No pheno-
typic differences were observed among the mice derived from
the three ES cell clones.
To generate constitutive Scn1a knock-out mice, Scn1a
ﬂ/ﬂ
mice were cross-mated with EIIA-Cre mice maintained on a
C57BL/6J background (22). Heterozygous (Scn1a
ﬂ/+,
EIIA-Cre) offspring were subsequently backcrossed with
C57BL/6J mice to obtain Scn1a
d/+ mice lacking the EIIA-Cre
transgene. Absence of the EIIA-Cre transgene was veriﬁed by
PCR analysis. Homozygous (Scn1a
d/d) mice were obtained by
interbreeding Scn1a
d/+ mice.
VGAT (also known as vesicular inhibitory amino acid trans-
porter, Viaat)-Cre BAC transgenic mice were generated using
a BAC Tg construct made with the Red/ET recombination
system(GeneBridges,GmbH,Dresden,Germany),asprevious-
ly described (59). Brieﬂy, the Cre-Km cassette, containing Cre
recombinase followed by SV40 poly(A) and kanamycin-
resistantgenes,wasPCR-ampliﬁedusingDNApolymerasePyr-
obest (Takara Bio) and the primer set: 5′-TCC TCG CTG CCT
TGA CGC GCG CCC GCC GCG TCC CCA GAC CCT TCT
GTC CTT TTC TCT CGA CCT GCA GCC CAA GCT GTA
CC-3′ and 5′-GGC CTG GGA CTT GTT GGA CAC GGA
GGT GGC CAC ATT GGT CAG CTT GCT GCG GAG CAC
TAA ATA CAT TCA AAT ATG TAT CC-3′.A nEscherichia
coli strain, containing an RP23-392-P11 BAC clone derived
from C57BL/6 mouse genomic DNA (Roswell Park Center In-
stitute, Buffalo, NY, USA) and covering 124 kb upstream and
72 kb downstream of the translational initiation site of the
Vgat gene, was transformed with pSC101-BAD-gbaA (Gene
Bridges) and subsequently with puriﬁed PCR products. The
resulting BAC Tg construct was veriﬁed by restriction enzyme
digestion and DNA sequencing. The construct was linearized
by PI-SceI and puriﬁed using Sepharose columns. The fraction
containing the Tg construct was identiﬁed by pulsed-ﬁeld gene
electrophoresis (FIGE Mapper, Bio-Rad). The puriﬁed DNA
fragment was injected into pronuclei of fertilized eggs from
C57BL/6 mice to generate Tg mice. Tg65, the Tg mouse line
used in this study, has been maintained on a C57BL/6 genetic
background. Heterozygous (Scn1a
ﬂ/+,VGAT-Cre) mice were
obtained by cross-mating Scn1a
ﬂ/ﬂ mice and VGAT-Cre mice.
Homozygous (Scn1a
ﬂ/ﬂ,VGAT-Cre) mice were generated as
described below.
Emx1-Cre KI mice without a neomycin cassette were
described previously (26,60,61), and maintained on a C57BL/
6J background. Heterozygous (Scn1a
ﬂ/+, Emx1-Cre) mice
were obtained by cross-mating Scn1a
ﬂ/ﬂ mice and Emx1-Cre
mice, and subsequently backcrossed with Scn1a
ﬂ/ﬂ mice to
obtain homozygous (Scn1a
ﬂ/ﬂ, Emx1-Cre) mice. Scn1a
ﬂ/ﬂ,
Emx1-Cre mice were then cross-mated with VGAT-Cre mice
to obtain Scn1a
ﬂ/+, Emx1-Cre,VGAT-Cre mice.
In order to obtain Scn1a
ﬂ/ﬂ,VGAT-Cre mice, we cross-mated
Scn1a
ﬂ/+, Emx1-Cre,VGAT-Cre mice and Scn1a
ﬂ/ﬂ mice.
However, these crosses yielded only 1 (1 of 96, from 13 litters)
Scn1a
ﬂ/ﬂ,VGAT-Cre mouse, suggesting that the ﬂoxed
Scn1a and VGAT-Cre transgene alleles in Scn1a
ﬂ/+,
Emx1-Cre,VGAT-Cre progenitors were mapped close together
on the same chromosome and arranged in trans-conﬁguration.
To obtain Scn1a
ﬂ/+, Emx1-Cre,VGAT-Cre offspring in which
the ﬂoxed Scn1a and VGAT-Cre transgene alleles were located
in cis-conﬁguration, Scn1a
ﬂ/+, Emx1-Cre,VGAT-Cre progeni-
tors were bred with Emx1-Cre or C57BL/6J mice. Triple-
heterozygous offspring were subsequently crossed with
Scn1a
ﬂ/ﬂ mice to obtain Scn1a
ﬂ/ﬂ,VGAT-Cre mice, whereas
Scn1a
ﬂ/+ offspring were crossed with Scn1a
ﬂ/ﬂ mice to obtain
Scn1a
ﬂ/ﬂ controls.
Pvalb-Cre transgenic (PV-Cre-TG) mice express Cre in the
majorityofPVcells—werepreviouslydescribed(42),andmain-
tained on a C57BL/6J background. Heterozygous (Scn1a
ﬂ/+,
PV-Cre-TG) mice were obtained by cross-mating Scn1a
ﬂ/ﬂ
mice and PV-Cre-TG mice. Homozygous (Scn1a
ﬂ/ﬂ,
PV-Cre-TG) mice were obtained by backcrossing Scn1a
ﬂ/+,
PV-Cre-TG mice with Scn1a
ﬂ/ﬂ mice. Crosses between
Scn1a
ﬂ/+, PV-Cre-TG females and Scn1a
ﬂ/ﬂ males produced
Scn1a
ﬂ/d, PV-Cre-TG and Scn1a
ﬂ/d mice, in addition to Scn1a
ﬂ/ﬂ,
Human Molecular Genetics, 2013, Vol. 22, No. 23 4801PV-Cre-TG, Scn1a
ﬂ/ﬂ, Scn1a
ﬂ/+, PV-Cre-TG and Scn1a
ﬂ/+mice.
This suggests that PV-Cre-TG-mediated recombination occurred
in female germline cells.
Pvalb-IRES-Cre knock-in (PV-Cre-KI) mice, with an
IRES-Cre cassette inserted into the 3′ untranslated region of
the mouse Pvalb allele through gene targeting, were described
previously (48). PV-Cre-KI mice express Cre only in PV cells
(49–52). PV-Cre-KI mice were obtained on a C57BL6/129
mixed background from the Jackson laboratory (JAX#008069;
Bar Harbor, ME, USA) and maintained on a C57BL/6J back-
ground. Heterozygous (Scn1a
ﬂ/+, PV-Cre-KI) mice were
obtained by cross-mating Scn1a
ﬂ/ﬂ mice and PV-Cre-KI mice
and subsequently backcrossed with Scn1a
ﬂ/ﬂ mice to obtain
homozygous (Scn1a
ﬂ/ﬂ, PV-Cre-KI) mice.
A Rosa26-LacZ transgenic reporter mouse strain for Cre-
mediated recombination was described previously (25). The
LacZcodingsequencewasfusedtoanuclearlocalizationsignal.
A Gad67-GFP mouse strain for the labeling of inhibitory
neurons was described previously (29).
Electrocorticographic recordings
Stainless steel screws (1.1 mm diameter) served as electrocorti-
cographic electrodes and were implanted over the somatosen-
sory cortex (1.5 mm lateral to midline, 1.0 mm posterior to
bregma) under 1.5% halothane anesthesia with N2O:O2 (3:2)
ventilation.Agroundelectrodewasimplantedonthecerebellum
(at midline, 2.0 mm posterior to lambda). Electromyogram
(EMG) electrodes were also placed in the cervical region of
the trapezius. Low-amplitude fast ECoG activity, together with
high levels of EMG activity, indicates that the mouse was
awake. Large-amplitude slow ECoG activity with low levels of
EMG activity indicates the mouse was in a resting or sleeping
state.
Western blot analysis
Brains were isolated from mice and homogenized in homogen-
ization buffer [0.32 M sucrose, 10 mM HEPES, 2 mM EDTA
and 1× complete protease inhibitor cocktail (Roche Diagnos-
tics,Indianapolis,IN,USA),pH7.4].Homogenateswerecentri-
fuged for 15 min at 1000g, with resulting supernatants
centrifuged for 30 min at 30 000g. Pellets were subsequently
resuspended in lysis buffer (50 mM HEPES and 2 mM EDTA,
pH7.4)andcentrifugedfor30 minat30 000g.Totalbrainmem-
brane proteins were dissolved in 2 M urea, 1× NuPAGE redu-
cing agent (Life Technologies) and 1× NuPAGE LDS sample
buffer (Life Technologies), separated on NuPAGE Novex
Tris–acetate 3–8% gels (Life Technologies), transferred to
nitrocellulosemembranes(Bio-Rad)andimmunoblotted.Mem-
branes were probed with rabbit anti-C-terminal Nav1.1 (IO1;
250 ng/ml; 15) and mouse anti-b-tubulin (T0198; 1:10 000;
Sigma-Aldrich, St Louis, MO, USA) antibodies. Membranes
were then incubated with horseradish peroxidase-conjugated
goat anti-mouse IgG (1:5000; Promega, Madison, WI, USA)
or goat anti-rabbit IgG (1:2000; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) antibodies. Bound antibodies were
detectedusingenhancedchemiluminescencereagent(PerkinEl-
mer,Boston,MA,USA).Semi-quantitationofproteinswasper-
formed using the NIH ImageJ software (National Institutes of
Health,Bethesda,MD,USA).Meanexpressionlevelswereesti-
matedbycomparisonwithserialdilutionsofhomogenatesfrom
age-matched control mice and represented as percentages rela-
tive to control mice. Statistical comparisons were made using
Student’s t-tests.Values withP , 0.05 wereconsideredsigniﬁ-
cant. At least two independent assays were performed.
Immunohistochemistry and immunoﬂuorescence
histochemistry
Micewere deeplyanesthetizedandperfusedtranscardially with
4%paraformaldehydeinPBS(10 mMphosphatebuffer,2.7 mM
KCl and 137 mM NaCl, pH 7.4). Brains were removed from the
skull,postﬁxedin4%paraformaldehydeinPBSfor24or4 h(only
for X-gal staining) at 48C and cryoprotected in 30% sucrose in
PBS. Free-ﬂoating sections of mouse brains (30 mm) were incu-
bated in 10 mM citric acid (pH 6.0) and 1 mM EDTA (pH 8.0) at
1008C for 20 min, blocked with4% BlockAce (DS PharmaBio-
medical, Osaka, Japan) in PBS for 1 h at room temperature and
incubated with rabbit anti-C-terminal Nav1.1 antibody (IO1;
250 ng/ml;15)for3overnights( 50 h)atroomtemperature.En-
dogenous peroxidases were quenched by incubation with 0.3%
hydrogen peroxide in PBS. The sections were then incubated
withbiotinylatedgoatordonkeypolyclonalsecondaryantibody
(1:200;Vector,Burlingame,CA,USA).Detectionofantibody–
antigen complexes was performed using Vectastain Elite ABC
(Vector) and Nova Red (Vector) kits. Sections were then
mounted ﬂat on glass slides.
Immunoﬂuorescence histochemistry was performed using
rabbit anti-GABA (A2052; 1:4000; Sigma-Aldrich) and chicken
anti-b-galactosidase (ab9361; 1:10000; Abcam) antibodies. Sec-
ondaryantibodieswereAlexaFlour488-,594-and647-conjugated
(1:1000;LifeTechnologies).SectionswerewashedwithPBScon-
taining 4′6-diamidino-2-phenylindole (DAPI; Nacalai Tesque,
Kyoto, Japan) and mounted with ProLongGold (Life Technolo-
gies). Images were obtained with a TCS SP2 microscope (Leica
Microsystems, Wetzlar, Germany) and processed using Adobe
Photoshop Elements 4.0 (Adobe Systems, San Jose, CA, USA).
Brain sections mounted on MAS-coated slide glasses (Matsunami
S9441) (10 mm) or ﬂoating (40 mm) were also stained with LacZ
substrate solution (1 mg/ml X-gal, 2 mM MgCl2,5m M K3FeCN6,
5m MK4FeCN6in PBS) overnight at 378C and subsequently incu-
bated with an antibody against GABA (1:2000) at 48C overnight.
After incubation in biotinylated goat anti-rabbit IgG (1:200) at
room temperature for 1 h, sections were incubated in Vectastain
Elite ABC Kit (PK-6101; Vector) for 1 h at room temperature.
Signals were detected by 5 min DAB treatment.
For immunohistochemistry double-staining on Gad67-GFP
mice (29), mice were perfused transcardially with periodate-
lysine-4% paraformaldehyde solution (PLP; 10 mM NaIO4,
75 mMlysine,37.5 mMphosphatebuffer,with4%paraformalde-
hyde).Brainswereremoved,postﬁxedinPLPsolutionovernight
at48Candparafﬁn-embedded.Parafﬁn-embeddedmousebrains
were sectioned (6 mm), incubated for 12 h at 488C and stored at
room temperature. Sections were then deparafﬁnized, rehy-
drated and microwaved in 1 mM EDTA, pH 8.0. After blocking
slides with 4% BlockAce solution in PBS containing 0.05%
Tween20,sectionswereincubatedwithgoatanti-internal-region
Nav1.1 antibody (C-18; 1:500; Santa Cruz Biotechnology) and a
mixture of monoclonal anti-GFP antibodies (1:500; Roche
4802 Human Molecular Genetics, 2013, Vol. 22, No. 23Diagnostics) for 12–15 h at 48C. Endogenous peroxidases were
quenched by incubation with 0.3% hydrogen peroxide in PBS.
Detection of antibody–antigen complexes was performed using
the Vectastain ABC-AP kit (Vector Laboratories), containing
Vector NovaRed substrates and producing red reaction products,
and the alkaline phosphatese substrate kit III (Vector Laborator-
ies) containing Vector Blue substrates and producing blue reac-
tion products, according to the manufacturer’s instructions.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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